SOLOVECIN Trademark

Trademark Overview


On Monday, August 19, 2024, a trademark application was filed for SOLOVECIN with the United States Patent and Trademark Office. The USPTO has given the SOLOVECIN trademark a serial number of 98705722. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, June 26, 2026. This trademark is owned by Dechra Veterinary Products, LLC. The SOLOVECIN trademark is filed in the Pharmaceutical Products category with the following description:

Antibiotics for veterinary use
solovecin

General Information


Serial Number98705722
Word MarkSOLOVECIN
Filing DateMonday, August 19, 2024
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, June 26, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 25, 2025

Trademark Statements


Goods and ServicesAntibiotics for veterinary use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 19, 2024
Primary Code005
First Use Anywhere DateTuesday, October 28, 2025
First Use In Commerce DateTuesday, October 28, 2025

Trademark Owner History


Party NameDechra Veterinary Products, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressOverland Park, KS 66211
US

Party NameDechra Veterinary Products, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressOverland Park, KS 66211
US

Trademark Events


Event DateEvent Description
Monday, August 19, 2024NEW APPLICATION ENTERED
Monday, August 19, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 25, 2025ASSIGNED TO EXAMINER
Friday, February 28, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 19, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 25, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 25, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 20, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 3, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 3, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 3, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 21, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, October 21, 2025SOU EXTENSION 1 FILED
Tuesday, October 21, 2025SOU EXTENSION 1 GRANTED
Wednesday, October 22, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 26, 2026TEAS STATEMENT OF USE RECEIVED
Thursday, March 26, 2026USE AMENDMENT FILED
Tuesday, June 23, 2026STATEMENT OF USE PROCESSING COMPLETE
Friday, June 26, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 26, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords


solovecin veterinary antibiotics